Clinical Trial Update: SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects [NA]

View source ↗

Summary

Clinical trial update for SURGICEL Powder evaluating control of mild to moderate intraoperative bleeding in adults; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Drugs mentioned

• SURGICEL Powder (oxidized regenerated cellulose)

Snippet

Sponsor: Ethicon, Inc. | Conditions: Hemorrhage | NA | Status: COMPLETED | Results posted: 2020-12-22